Astrocytoma Drug Market is driven by Targeted Therapy Innovations

ein Foto hinzugefügt Other

2025-05-14 14:50:12 -

The Astrocytoma Drug Market encompasses a range of pharmaceutical therapies designed to treat astrocytoma, a malignant brain tumor arising from astrocytes. Key products include alkylating agents like temozolomide, anti-VEGF antibodies such as bevacizumab, and novel small-molecule inhibitors targeting molecular pathways (e.g., EGFR, BRAF). Astrocytoma Drug Market Innovative drug formulations...

0 Kommentare 0 Anteile 101 Ansichten 0 Vorschau